Company: XAIR
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001641172-25-023243
Chunk: 93

Company: Beyond Air, Inc.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part II, Item 8
Chunk 93
---
 statements of historical facts contained in
this Form 10-Q, including statements regarding our future results of operations and financial position, business strategy, prospective
product candidates and products, product approvals, timing of our clinical development activities, research and development costs, timing
and likelihood of success and the plans and objectives of management for future operations and future results of anticipated products
are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may
cause our actual results, performance or achievements to be materially different from any future results, performance or achievements
express or implied by the forward-looking statements.

In
some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,”
“expect,” “plan,” “anticipate,” “expect,” “could,” “intend,”
“target,” “project,” “contemplate,” “believe,” “estimate,” “predict,”
“potential” or “continue” or the negative of these terms or other similar conditional expressions. The forward-looking
statements in this Form 10-Q are only predictions. We have based these forward-looking statements largely on our current expectations
and projections about future events and financial trends that we believe may affect our business, financial condition and results of
operations. These forward-looking statements speak only as of the date of this Form 10-Q and are subject to a number of important factors
that could cause actual results to differ materially from those in the forward-looking statements, including the factors described under
the sections in this Form 10-Q titled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition
and Results of Operations,” Item 1A “Risk Factors” contained in our most recently filed Annual Report on Form 10-K,
as well as the following:

    ●
    our
    ability to successfully commercialize our LungFit® PH system in the U.S.;

    ●
    our
    expectation to incur losses for the next year;

    ●
    our
    ability to predict accurately the demand for our products, and products under development and to develop strategies to address markets
    successfully;

    ●
    the
    possibility that products may contain undetected errors or defects or otherwise not perform as anticipated;

    ●
    the
    anticipated development of markets we sell our products into and the success of our products in these markets;

    ●
    our
    future capital needs and our need to raise additional funds;

    ●